Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Sprott Uranium Miners ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Sprott Uranium Miners ETF trades at $46.4 (market cap $1.87B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 2.5× Sprott Uranium Miners ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Sprott Uranium Miners ETF for 60 Days on average.
| DFTX | URNM | |
|---|---|---|
Market Cap | $4.71B | $1.87B |
Volume | 1,966,636 | 495,553 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $48.45 | $83.99 |
52-Week Low | $10.68 | $46.09 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $3.67B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
URNM (Sprott Uranium Miners ETF) trades at $47.87, down 4.83% today amid bearish technical signals. The ETF faces selling pressure with 13 bearish moving average indicators versus zero bullish signals. Despite the near-term weakness, uranium fundamentals remain strong with spot prices up 21.25% over the past year according to Sprott Asset Management data from August 2026. Recent government commitments to nuclear energy and AI-driven power demand create long-term growth catalysts.
The uranium sector faces near-term volatility but offers compelling long-term exposure to nuclear energy expansion. Key risks include uranium price fluctuations and regulatory uncertainty, while opportunities stem from $17.5 billion in U.S. nuclear funding and growing AI power needs. Analyst sentiment leans bullish on the sector's structural supply deficit and rising demand from data centers and government initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
